<DOC>
	<DOCNO>NCT00959244</DOCNO>
	<brief_summary>RATIONALE : Studying sample urine patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look urine sample woman newly diagnose breast cancer .</brief_summary>
	<brief_title>Study Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled Clinical Trial UNMC-08105</brief_title>
	<detailed_description>OBJECTIVES : - To learn effect select agent ( tamoxifen aromatase inhibitor ) profile estrogen metabolite , glutathione conjugate , depurinating DNA adduct urine woman breast cancer . OUTLINE : Previously collect urine sample analyze 40 estrogen metabolite , conjugate , depurinating DNA adduct ultra-performance liquid chromatography tandem mass spectrometric detection . Patient information ( e.g. , race , body mass index , age menarche , menopausal status , age menopause applicable , smoke history , alcohol consumption ) collect medical record review .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose ductal carcinoma situ invasive breast cancer Urine biospecimens available participation protocol UNMC08105 ( IRB # 31106 ) , Breast Cancer Collaborative Registry ( BCCR ) , include treatment tamoxifen aromatase inhibitor Urine specimens collect baseline , 6 month , annually Estrogen receptor progesterone receptor positive PATIENT CHARACTERISTICS : Menopausal status specify ECOG performance status 02 Not pregnant nursing PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent use estrogen ( )</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>